H. Cheng
University of Defence
4 Papers
3 Citations
H. Cheng is an academic researcher from University of Defence. The author has contributed to research in topics: Cancer & Cervical cancer. The author has an hindex of 1, co-authored 1 publications.
Chat about Author
Papers
Design of broadband microwave absorber utilizing FSS screen constructed with coupling configurations
Sun Liang Kui,J. Wang,H. Cheng,Y. Zhou +3 more
- 04 Jan 2012
TL;DR: In this article, the design of a frequency selective surface (FSS) screen constructed using a coupling configuration to implement a broadband microwave absorber is presented, and the reflectivity representation recognizes the characterization of the absorber.
3
180O Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
X Wu,Liming Xia,Ji Wang,C. Wang,Q. Zhang,J. Zhu,Qian Wen Rao,H. Cheng,Z. Liu,Y. Yin,Xin Lei Ai,Kurban Gulina,H. S. Zheng,X. Luo,B Chang,L. Li,H.L. Liu,Y. Li +17 more
TL;DR: Zimberelimab as discussed by the authors is a fully human anti-PD-1 monoclonal antibody with high affinity and selectivity for PD-1, which has been shown to be effective in patients with programmed death ligand-1-positive recurrent or metastatic cervical cancer that had progressed after first or subsequent-line platinumcontaining standard chemotherapy.
1
79P Efficacy and safety of zimberelimab (GLS-010) monotherapy in patients with recurrent or metastatic cervical cancer: A multicenter, open-label, single-arm, phase II study
X Wu,Liming Xia,J. Wang,C. Wang,Q. Zhang,J. Zhu,Qian Wen Rao,H. Cheng,Z. Liu,Y Yin,Xin Lei Ai,Kurban Gulina,H. S. Zheng,X. Luo,B Chang,L. Li,H. Liu,Y. Li +17 more
TL;DR: Zimberelimab as discussed by the authors is a fully human anti-PD-1 monoclonal antibody with high affinity and selectivity for PD-1, which has been shown to be effective in patients with programmed death ligand-1-positive recurrent or metastatic cervical cancer.
[Fibrocartilaginous lipoma: a clinicopathological analysis of six cases].
H. L. Li,J Wang,H. Cheng,S. Zhang,Rong-jun Mao +4 more
- 08 Aug 2023
TL;DR: Fibrocartilaginous lipoma is a benign lipomatous tumor with mature adipocytes, fibrocartilage and fibrous elements that helps the distinction from its morphologic mimics.